Neuroepidemiology · 2002 · 26 citations · 25 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyDementiaGeriatric PharmacologyCognitive ImpairmentDementia EpidemiologyDementia PreventionMedication UseNeurodegenerative Disease PharmacotherapyPharmacoepidemiologyAnalgesic Use In DementiaCase By Case AnalysisDrug Interactions In DementiaDrug Use DisorderMedication Effects On CognitionNonsteroidal Anti-inflammatory Drug SafetyNsaid TherapyPharmacological Treatment Of Dementia
In many studies of nonsteroidal anti-inflammatory drugs (NSAIDs) and Alzheimer's disease (AD), the exposure to NSAIDs was concurrent with AD or based on self (or surrogate) report. We conducted a case-control analysis of the Québec participants in the Canadian Study of Health and Aging who received a diagnosis of AD (cases) or were found to be cognitively unimpaired on screening (controls). Information on drug use was obtained from the Québec Provincial Pharmaceutical Services Database. There was no significant difference in the proportion of cases and controls who had received any NSAID prescriptions in the 3 years prior to the onset of symptoms of dementia; amongst NSAID users, there was no difference in mean dose or duration. Our findings, using a measure of drug use prior to symptom onset and not subject to recall bias, do not support a protective effect for NSAIDs.
25
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text
The Modified Mini-Mental State (3MS) examination.
Evelyn L. Teng, Helena Chui · PubMed · 1987 · 2.7K citations
Risk of Alzheimer's disease and duration of NSAID use
Walter F. Stewart, Claudia H. Kawas, María M. Corrada et al. · Neurology · 1997 · 1.1K citations · Full text